echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Plos Genet: Ordinary people are naturally resistant to SARS-CoV-2

    Plos Genet: Ordinary people are naturally resistant to SARS-CoV-2

    • Last Update: 2021-02-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    FEBRUARY 12, 2021 /--- According to a study published February 11 in the open-access journal PLOS Pathogen, in the majority of severe cases of COVID-19, most people can produce meso-antibodies against SARS-CoV-2.
    study was conducted by Michael Mor of Tel Aviv University and colleagues.
    , results support the prevention and treatment of COVID-19 using combination antibody therapy.
    THE COVID-19 pandemic caused by SARS-CoV-2 has had a profound impact on global public health.
    it is believed that neutral antibodies specific to the SARS-CoV-2 protrusion protein binding domain (RBD) are essential for controlling viruses.
    RBD-specific neutral antibodies were detected in patients recovering from COVID-19.
    some of the participants tended to have strong and long-lasting immunity, while others showed a decrease in the antibody.
    , however, what factors affect effectiveness and the long-lasting antibody response remains unclear.
    (Photo Source: Www.pixabay.com) To address this problem, Mor and colleagues used molecular and biometric techniques to compare B-cell responses in 8 patients with severe COVID-19 and 10 patients with mild symptoms in 1.5 months after infection.
    patients with severe illness showed higher concentrations of RBD-specific antibodies and increased B-cell amplification.
    of the 22 antibodies cloned from two of the patients, six showed effective mesosing against SARS-CoV-2.
    bio-information analysis shows that in severe COVID-19 cases, most people will be able to easily produce meso-antibodies against SARS-CoV-2.
    , the combination of different types of meso-antibodies completely prevents the spread of live viruses.
    that these antibody mixtures could be further tested in clinical settings as a useful tool for preventing and treating COVID-19.
    , the authors added: "Even if vaccines are available, it is important to provide special anti-SARS-CoV-2 therapies to health care providers.
    and antibodies represent an effective and safe way to treat severe COVID-19 cases, especially in the elderly or chronically ill people who cannot easily produce these antibodies after infection or vaccination.
    " (Bioon.com) Source: Most people are naturally armed against SARS-CoV-2: Study Original source: Mor M, Werbner M, Alter J, Safra M, Chomsky E, Lee JC, et al. (2021) Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors. PLoS Pathog 17(2): e1009165. doi.org/10.1371/journal.ppat.1009165
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.